Interstitial infusion of erlotinib in the rodent brain

Journal of Experimental Therapeutics and Oncology

Volumn 8, Issue 2, 2009, Pages 79-84

  Luther, Neal ^a   Karampelas, Ioannis ^a   Souliopoulos, Eleni P ^a   Edgar, Mark A ^b   Boockvar, John A ^a   Souweidane, Mark M ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Convection; EGFR; Erlotinib; Glioma; Infusion; Tarceva

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CANCER INHIBITION; CORPUS STRIATUM; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG TARGETING; GLIOBLASTOMA; HISTOPATHOLOGY; IC 50; INTERSTITIAL INFUSION; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; BRAIN; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; MICROINJECTIONS; NEOSTRIATUM; QUINAZOLINES; RATS; RATS, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 74049111973     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Prados, M., Lang, F. F., Sherman, J. W., Strauss, L. C., Fleming, C. K., Aldape, K., Kunwar, S., Yung, W. K. A., Chang, S. M., Husain, S. R., Gutin, P. H., Raizer, J., Piepmeier, J. M., Berger, M., McDermott, M., Puri, R. K. Convection-enhanced delivery (CED) by positive pressure infusion for intra-tumoral and pretumoral administration of IL13-PE38QQR a recombinant tumor-targeted cytotoxin in recurrent malignant glioma. Neurooncol, 4: S78, 2002.
2. Olivi, A., Grossman, S. A., Tatter, S., Barker, F., Judy, K., Olsen, J., Bruce, J., Hilt, D., Fisher, J., and Piantadosi, S. Dose Escalation of Carmustine in Surgically Implanted Polymers in Patients With Recurrent Malignant Glioma: A New Approaches to Brain Tumor Therapy CNS Consortium Trial. J Clin Oncol, 21: 1845-1849, 2003.
3. Raizer, J. J., Malkin, M. G., Kleber, M., and Abrey, L. E. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy. Neurooncol, 6: 247-252, 2004.
4. Kondziolka, D., Flickinger, J. C., Bissonette, D. J., Bozik, M., and Lunsford, L. D. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery, 41: 776-783; discussion 783-775, 1997.
5. Morrison, P. F., Laske, D. W., Bobo, H., Oldfield, E. H., Dedrick, R. L. High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol, 266: R292-R305, 1994.
6. Bobo, R. H., Laske, D. W., Akbasak, A., Morrison, P. F., Dedrick, R. L., Oldfield, E. H. Convection-enhanced delivery to macromolecules in the brain. Proc. Nat. Acad. Sci. USA, 91: 2076-2080, 1994.
7. Groothuis, D. R., Ward, S.; Itskovich, A. C.; Dobrescu, C.; Allen, C. V.; Dills, C.; Levy, R. M. Comparison of 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion. J Neurosurg, 90: 321-331, 1999.
8. Laske, D. W., Morrison, P. F, Lieberman, D. M., Corthesy, M. E., Reynolds, J. C., Stewart-Henney, P. A., Koong, S. S., Cummins, A, Paik, C. H., Oldfield, E. H. Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg, 87: 586-594, 1997.
9. Lidar, Z., Mardor, Y., Jonas, T., Pfeffer, R., Faibel, M., Nass, D., Hadani, M., Ram, Z. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioms: a Phase I/II clinical study. J Neurosurg, 100: 472-479, 2004.
10. Sampson, J. H., Akabani, G., Archer, G.E., Bigner, D.D., Berger, M.S., Friedman, A.H., Friedman, H.S., Herndon, J.E. 2nd, Kunwar, S., Marcus, S., McLendon, R.E., Paolino, A., Penne, K., Provenzale, J., Quinn, J., Reardon, D.A., Rich, J., Stenzel, T., Tourt-Uhlig, S., Wikstrand, C., Wong, T., Williams, R., Yuan, F., Zalutsky, M.R., Pastan, I. Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J Neurooncol, 65: 27-35, 2003.
11. Kunwar, S. Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. Acta Neurochir Suppl, 88: 105-111, 2003.
12. Fry, D. W. Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors. Pharmacology & Therapeutics, 82: 207-218, 1999.
13. Sarkaria, J. N., Carlson, B. L., Schroeder, M. A., Grogan, P., Brown, P. D., Giannini, C., Ballman, K. V., Kitange, G. J., Guha, A., Pandita, A., and James, C. D. Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clinical Cancer Research, 12: 2264-2271, 2006.
14. Haas-Kogan, D. A., Prados, M. D., Tihan, T., Eberhard, D. A., Jelluma, N., Arvold, N. D., Baumber, R., Lamborn, K. R., Kapadia, A., Malec, M., Berger, M. S., and Stokoe, D. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.[see comment]. Journal of the National Cancer Institute, 97: 880-887, 2005.
15. Efferth, T., Ramirez, T., Gebhart, E., and Halatsch, M. E. Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774. Biochemical Pharmacology, 67: 1689-1700, 2004.
16. Lassman, A. B., Rossi, M. R., Raizer, J. J., Abrey, L. E., Lieberman, F. S., Grefe, C. N., Lamborn, K., Pao, W., Shih, A. H., Kuhn, J. G., Wilson, R., Nowak, N. J., Cowell, J. K., DeAngelis, L. M., Wen, P., Gilbert, M. R., Chang, S., Yung, W. A., Prados, M., and Holland, E. C. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.[erratum appears in Clin Cancer Res. 2006 Jan 1;12(1):322 Note: Razier, Jeffrey R [corrected to Raizer, Jeffrey J]]. Clin Cancer Res, 11: 7841-7850, 2005.
17. Ekstrand, A. J., Sugawa, N., James, C. D., and Collins, V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proceedings of the National Academy of Sciences of the United States of America, 89: 4309-4313, 1992.
18. Frederick, L., Wang, X. Y., Eley, G., and James, C. D. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res, 60: 1383-1387, 2000.
19. Luther, N., Cheung, N. K., Dunkel, I. J., Edgar, M. A., Fraser, J. F., Gutin, P. H., and Souweidane, M. M. Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9. Neurosurgery, 63: 1166-1174, 2008.
20. Souweidane, M. M., Occhiogrosso, G, Mark, E. B., Edgar, M. A., Dunkel, I. J. Interstitial Infusion of Carmustine in the Rat Brainstem with Systemic Administration of O6-Benzylguanine. J Neuro-Oncol, 67: 305-317, 2004.
21. Sandberg, D. I., Edgar, M. A., Souweidane, M. M. Convection-enhanced delivery into the rat brain stem. J Neurosurg, 96: 885-891, 2002.
22. Kunwar, S., Prados, M. D., Chang, S. M., Berger, M. S., Lang, F. F., Piepmeier, J. M., Sampson, J. H., Ram, Z., Gutin, P. H., Gibbons, R. D., Aldape, K. D., Croteau, D. J., Sherman, J. W., Puri, R. K., and Cintredekin Besudotox Intraparenchymal Study, G. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol, 25: 837-844, 2007.
23. Rand, R., Kreitman, R. J., Patronas, N., Varricchio, F., Pastan, I., Puri, R. K. Intratumoral Administration of Recombinant Circularly Permuted Interleukin-4-Pseudomonas Exotoxin in Patients with High-Grade Glioma. Clin Cancer Res, 6: 2157-2165, 2000.
24. Puri, R., Hoon, D. S., Leland, P., Snoy, P., Rand, R. W., Pastan, I., Kreitman, R. J. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma. Cancer Res, 56: 5631-5637, 1996.
25. Debinski, W., Gibo, Denise M.; Hulet, Stanley W.; Connor, James R.; Gillespie, G. Yancey Receptor for Interleukin 13 Is a Marker and Therapeutic Target for Human High-Grade Gliomas. Clin Cancer Res, 5: 985-990, 1999.
26. Raizer, J. J. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme. J Neurooncol, 74: 77-86, 2005.
27. Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H., Chute, D. J., Riggs, B. L., Horvath, S., Liau, L. M., Cavenee, W. K., Rao, P. N., Beroukhim, R., Peck, T. C., Lee, J. C., Sellers, W. R., Stokoe, D., Prados, M., Cloughesy, T. F., Sawyers, C. L., and Mischel, P. S. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med, 353: 2012-2024, 2005.
28. Belda-Iniesta, C., Carpeno Jde, C., Saenz, E. C., Gutierrez, M., Perona, R., and Baron, M. G. Long term responses with cetuximab therapy in glioblastoma multiforme.[see comment]. Cancer Biology & Therapy, 5: 912-914, 2006.
29. Wu, G., Yang, W., Barth, R. F., Kawabata, S., Swindall, M., Bandyopadhyaya, A. K., Tjarks, W., Khorsandi, B., Blue, T. E., Ferketich, A. K., Yang, M., Christoforidis, G. A., Sferra, T. J., Binns, P. J., Riley, K. J., Ciesielski, M. J., and Fenstermaker, R. A. Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab. Clin Cancer Res, 13: 1260-1268, 2007.
30. Lustig, R. Long term responses with cetuximab therapy in glioblastoma multiforme.[comment]. Cancer Biol & Ther, 5: 1242-1243, 2006.
31. Krishnan, S., Brown, P. D., Ballman, K. V., Fiveash, J. B., Uhm, J. H., Giannini, C., Jaeckle, K. A., Geoffroy, F. J., Nabors, L. B., Buckner, J. C., and North Central Cancer Treatment, G. Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177. Int J Rad Oncol, Biol, Phys, 65: 1192-1199, 2006.
32. Prados, M., Chang, S., Butowski, N., Deboer, R., Parvataneni, R., Carliner, H., Kabuubi, P., Ayers-Ringler, J., Rabbitt, J., Page, M., Fedoroff, A., Sneed, P., Berger, M., McDermott, M., Parsa, A., Vandenberg, S., James, C. L., K. R., Stokoe, D., and Haas-Kogan, D. Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma. J Clin Oncol, Dec 15 Epub, 2008.
33. Butowski, N., Lamborn, K. R., Berger, M. S., Prados, M. D., and Chang, S. M. Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. J Neuro-Oncol, 85: 87-94, 2007.
34. Liu, W., Makrauer, F. L., Qamar, A. A., Janne, P. A., and Odze, R. D. Fulminant hepatic failure secondary to erlotinib. Clin Gastroenterology & Hepatol, 5: 917-920, 2007.
35. Lieberman, D. M., Laske, D. W., Morrison, P. F. Bankiewicz, K. S.; Oldfield, E. H. Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg, 82: 1021-1029, 1995.
36. Lonser, R. R., Gogate, N., Morrison, P. F., Wood, J. D., Oldfield, E. H. Direct convective delivery of macromolecules to the spinal cord. J Neurosurg, 89: 616-622, 1998.
37. Nguyen, T. T., Pannu, Y. S., Sung, C, Dedrick, R. L, Walbridge, S., and Brechbiel, M. W., Garmestani, K., Beitzel, M., Yordanov, A., Oldfield, E. H. Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg, 98: 584-590, 2003.
38. Lonser, R. R., Walbridge, S., Garmestani, K., Butman, J. A., Walters, H. A., Vortmeyer, A. O., Morrison, Paul F., Brechbiel, M. W., Oldfield, E. Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg, 97: 905-913, 2002.
39. Kroll, R. A., Pagel, Michael A.; Muldoon, Leslie L.; Roman-; Goldstein, Simon; Neuwelt, Edward A. Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor. Neurosurg, 38: 746-754, 1996.
40. Betz, A. L., Shakui, P., Davidson, B.L. Gene transfer to rodent brain with recombinant adenoviral vectors: effects of infusion parameters, infectious titer, and virus concentration on transduction volume. Exp Neurol, 150: 136-142, 1998.
41. Cunningham, J., Oiwa, Y., Nagy, N., Podsakoff, G., Colosi, P., Bankiewicz, K. S. Distribution of AAV-TK following intracranial convection-enhanced delivery into rats. Cell Transplantation, 9: 585-594, 2000.
42. Nguyen, J. B., Sanchez-Pernaute, R., Cunningham, J., Bankiewicz, K. S. Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport, 12: 1961-1964, 2001.
43. Sampson, J. H., Akabani, G., Friedman, A. H., Bigner, D., Kunwar, S., Berger, M. S., and Bankiewicz, K. S. Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies. Neurosurg Focus, 20: E14, 2006.
44. Bruce, J. N., Falavigna, A., Johnson, J. P., Hall, J. S., Birch, B. D.,Yoon, J. T., Wu, E. X., Fine, R. L., Parsa, A. T. Intracerebral clysis in a rat glioma model. Neurosurgery, 46: 683-691, 2000.
45. Kaiser, M. G., Parsa, A. T., Fine, R. L., Hall, J. S., Chakrabarti, I., and Bruce, J. N. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model. Neurosurgery, 47:1391-1398, 2000.
46. Occhiogrosso, G., Edgar, M. A., Sandberg, D. I., Souweidane, M. M. Prolonged convection enhanced delivery into the rat brain stem. Neurosurgery, 52: 388-393, 2003.
47. Degen, J., Walbridge S., Vortmeyer, A. O., Oldfield, E. H., Lonser, R. R. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg, 99: 893-898, 2003.
48. Wood, J. D., Russell, B. S., Lonser, R., Gogate, N., Morrison, P. G., Oldfield, E. H. Convective delivery of macromolecules into the naive and traumatized spinal cords of rats. J Neurosurg (Spine 1), 90: 115-120, 1999.
49. Souweidane, M. M., Occhiogrosso, G., Mark, E. B., Edgar, M. A. Interstitial Infusion of IL13-PE38QQR in the Rat Brain Stem. J Neuro-Oncol, 67: 287-293, 2004.